Depression during pregnancy: detection, comorbidity and treatment (original) (raw)

Abstract

Depression during pregnancy is common (15%). Routine prenatal depression screening coupled with the use of physician collaborators to assist in connecting women with care is critical to facilitate treatment engagement with appropriate providers. Providers should be aware of risk factors for depression -including a previous history of depression, life events, and interpersonal conflict -and should appropriately screen for such conditions. Depression during pregnancy has been associated with poor pregnancy outcomes including preeclampsia, insufficient weight gain, decreased compliance with prenatal care, and premature labor. Current research has questioned the overall benefit of treating depression during pregnancy with antidepressants when compared to the risk of untreated depression for mother and child. Published guidelines favor psychotherapy above medication as the first line treatment for prenatal depression. Poor neonatal adaptation or withdrawal symptoms in the neonate may occur with fetal exposure in late pregnancy, but the symptoms are mild to moderate and transient. The majority of mothers who decide to stop taking their antidepressants during pregnancy suffer relapsing symptoms. If depression continues postpartum, there is an increased risk of poor mother-infant attachment, delayed cognitive and linguistic skills in the infant, impaired emotional development, and behavioral problems in later life. Bipolar depression, anxiety and substance use disorders, and/or presence of severe psychosocial stress can lead to treatment-resistance. Modified and more complex treatment algorithms are then warranted. Psychiatric medications, interpersonal or cognitive-behavioral therapy, and adjunctive parent-infant/family treatment, as well as social work support, are modalities often required to comprehensively address all issues surrounding the illness.

Figures (2)

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (56)

  1. Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007) (2008) Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol. 111(4), 1001-20.
  2. Alder J., et al. (2007) Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med. 20(3), 189-209.
  3. Altshuler L.L., Hendrick V., Cohen L.S. (1998) Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry. 59(Suppl 2), 29-33.
  4. Alwan S., et al. (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 356(26), 2684-92.
  5. Andrade S., et al. (2009) Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 18(3), 246-252.
  6. Beddoe A.E., Lee K.A. (2008) Mind-body interventions during pregnancy. J Obstet Gynecol Neonatal Nurs. 37(2), 165-75.
  7. Bhatia S.C., Bhatia S.K. (1999) Depression in women: diagnostic and treatment considerations. Am Fam Physician. 60(1), 225-34, 239-40.
  8. Bolton J.M., Robinson J., Sareen J. (2009) Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Affective Disorders. 115(3), 367-75.
  9. Chambers C.D., et al. (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 354(6), 579-87.
  10. Chang G., et al. (1998) Alcohol use and pregnancy: improving identification. Obstet Gynecol. 91(6), 892-8.
  11. Chudley A.E., et al. (2005) Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 172(suppl 5), S1-21.
  12. Chun-Fai-Chan B., et al. (2005) Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol. 192(3), 932-6.
  13. Cohen L.S., et al. (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. Jama. 295(5), 499-507.
  14. Cohen L.S. (2007) Treatment of bipolar disorder during pregnancy. J Clin Psychiatry. 68(Suppl 9), 4-9.
  15. Cox J.L., Holden J.M., Sagovsky R. (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 150, 782-6.
  16. Davis E., et al. (2007) Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry. 46(6), 737-46. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (2000) Washington, D.C.: American Psychiatric Association.
  17. Dolk H., et al. (2008) Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology. 71, 714-722.
  18. Einarson A., et al. (2008) Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry. 165(6), 749-52.
  19. Einarson A. (2009) Risks/safety of psychotropic medication use during pregnancy-Motherisk Update 2008. Can J Clin Pharmacol. 16(1), 58-65.
  20. Einarson A., et al. (2009) Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can. 31(5), 452-6.
  21. Einarson A., Selby P., Koren G. (2001) Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counseling. J Psychiatry Neurosci. 26(1), 44-8.
  22. Feinman J.A., et al. (2000) Development of a model for the detection and treatment of depression in primary care. Psychiatr Q. 71(1), 59-78.
  23. Ferreira E., et al. (2007) Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics. 119(1), 52-9.
  24. Fisher J.B., et al. (1985) Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol. 66(3 Suppl), 34S-35S.
  25. Freeman M.P., et al. (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 67(12), 1954-67.
  26. Gentile S. (2006) Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disord. 8(3), 207-20.
  27. GlaxoSmithKline. (2005) http://www.gsk.com/media/ paroxetine/pregnancy_hcp_letter.pdf. [cited June 19, 2008].
  28. Gonsalves L., Schuermeyer I. (2006) Treating depression in pregnancy: practical suggestions. Cleve Clin J Med. 73(12), 1098-104.
  29. Hemels M.E., et al. (2005) Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother. 39(5), 803-9.
  30. Holmes L.B., et al. (2001) The teratogenicity of anticonvulsant drugs. N Engl J Med. 344(15), 1132-8.
  31. Kessler R.C., et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 51(1), 8-19.
  32. Koren G., et al. (2005) Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? Cmaj. 172(11), 1457-9.
  33. Lester B.M., Twomey J.E. (2008) Treatment of substance abuse during pregnancy. Womens Health (Lond Engl) Jan(4): 67-77.
  34. Louik C., et al. (2007) First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 356(26), 2675-83.
  35. Marcus S.M., et al. (2003) Depressive symptoms among pregnant women screened in obstetrics settings. J Womens Health (Larchmt). 12(4), 373-80.
  36. McKenna K., et al. (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective compara- tive study. J Clin Psychiatry. 66(4), 444-9; quiz 546.
  37. Meyer C., Oberman M. (2001) Mothers Who Kill Their Children: Inside the Minds of Moms From Susan Smith to the ''Prom Mom.''. New York: New York University Press.
  38. Misri S., Kendrick K. (2007) Treatment of perinatal mood and anxiety disorders: a review. Can J Psychiatry. 52(8), 489-98.
  39. Morrow J.I., Craig J.J., Russell A.J.C. (2001) Epilepsy and pregnancy: a prospective register in the United Kingdom. J Neurol Sci. 187(suppl 1), S299.
  40. Nulman I., et al. (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med. 336(4), 258-62.
  41. O'Hara M.W., Neunaber D.J., Zekoski E.M. (1984) Prospective study of postpartum depression: prevalence, course, and predictive factors. J Abnorm Psychol. 93(2), 158-71.
  42. Parker B., McFarlane J., Soeken K. (1994) Abuse during pregnancy: effects on maternal complications and birth weight in adult and teenage women. Obstet Gynecol. 84(3), 323-8.
  43. Rabheru K. (2001) The use of electroconvulsive therapy in special patient populations. Canadian Journal of Psychiatry. 46(October), 710-719.
  44. Radloff L. (1977) The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement. 1, 385-401.
  45. Resnick H.S., et al. (1993) Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol. 61(6), 984-91.
  46. Robinson J., et al. (2009) Self-medication of anxiety disorders with alcohol and drugs: results from a nationally representative sample. Journal of Anxiety Disorders. 23(1), 38-45.
  47. Roeloffs C., et al. (2003) Stigma and depression among primary care patients. General Hospital Psychiatry. 25(5), 311-315.
  48. Ross A.S., et al. (2006) Antenatal & neonatal guidelines, education & learning system. J Ark Med Soc. 102(12), 328-30.
  49. Sharma V. (2006) A cautionary note on the use of antidepressants in postpartum depression. Bipolar Disord. 8(4), 411-4.
  50. Sharma V. (2009) Management of Bipolar II Disorder during Pregnancy and the Postpartum Period. Can J Clin Pharmacol. 16(1), 33-41.
  51. Viguera A.C., et al. (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 157(1), 179-84.
  52. Weissman M.M., Olfson M. (1995) Depression in women: implications for health care research. Science. 269(5225), 799-801.
  53. Westdahl C., et al. (2007) Social support and social conflict as predictors of prenatal depression. Obstet Gynecol. 110(1), 134-40.
  54. Wichman C., et al. (2009) Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy. Mayo Clin Proc. 84(1), 23-27.
  55. Widom C.S., Czaja S.J., Dutton M.A. (2008) Childhood victimization and lifetime revictimization. Child Abuse and Neglect. 32(8), 785-796.
  56. Yonkers K.A., et al. (2009) The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General Hospital Psychiatry. 31(5), 403-413.